Monsanto/Bayer Early Remedy Package Not Expected at European Commission

As the European Commission’s review of Bayer’s acquisition of Monsanto proceeds, Bayer is not planning to proactively offer remedies to the commission beyond thosefeatured

Monsanto and Bayer in Remedy Discussions with Indian Regulator

Monsanto and Bayer are in pre-phase 2 remedy negotiations with the Competition Commission of India, several antitrust sources familiarfeatured

Monsanto, Bayer Fail to Reach Divestment Agreement with CADE General Superintendence

Biotechnology giants Monsanto and Bayer could not reach a concentration control agreement (ACC) with CADE’s general superintendencefeatured

Australian Regulators Deferring to Europe and US in Monsanto/Bayer Deal

Australia’s competition regulator is taking a similar approach in reviewing and how it will ultimately decide on Bayer AG’s $66 billion acquisition of Monsantofeatured

360b /

Australian Competition and Consumer Commission Focusing on Crop Protection in Dow-DuPont Review

The European Commission on August 11 commenced a Phase II investigation into the proposed Dow Chemical-DuPont merger. The Australian Competition and Consumer Commission, meanwhile, is in the midst of conducting its own in-depth review.featured

Monsanto Progresses Soybean Business in Brazil

Monsanto is likely to profit from Brazil’s economic crisis, as the country − the world’s largest soybean exporter − strives to boost production and retain foreign investors amid an uncertain political and financial outlook. Sources told CTFN that Brazilian regulators are expected to approve Monsanto’s recent licensing agreement with rival Dupontfeatured

Monsanto Acquisition by Bayer Could See EC Consider Wider Effects

If a Bayer acquisition of Monsanto materializes, the European Commission could look at pro-forma industry dynamics in additional to horizontal overlaps and potential vertical foreclosure, analysts and observers told CTFN. Christoph Then, a coordinator at the No Patents On Seeds coalition, expressed overall concerns saying, “… Three mergers will have an impact on the landscape of R&D … Bayer and … Read Morefeatured

Bayer Keeps Close Watch on EU Deliberations on Monsanto’s Roundup

As Bayer AG contemplates a higher offer for Monsanto it will be keeping close tabs on the European Union’s ongoing debate about renewing the license for glyphosate, the active ingredient in Monsanto’s Roundup, the world’s leading herbicide for weed control. A ruling against glyphosate is not expected to drive off Bayer but could affect the … Read Morefeatured

Syngenta/ChemChina Merger Hinges on US Approval

The outcome of the planned $43 billion merger between Swiss biotech giant Syngenta and chemical conglomerate ChemChina will mainly depend on whether the parties receive US blessing for the deal, three lawyers familiar with the industry told CTFN. Henning Schneider, co-chair of the German Corporate Department and chair of the global Healthcare Industry Group at … Read Morefeatured

Monsanto/Bayer Deal to See Pushback from Farmers

The powerful farming lobby is already mobilizing opposition to the proposed merger of Bayer AG and Monsanto, which they see as further diminishing US farmers’ choices on seeds, pesticides, and other major agricultural supplies, while putting a greater portion of the US farming sector in foreign hands. “We used to have six major players in … Read Morefeatured


Interested in a trial?

Simply fill out the form below and one of our representatives will be in touch.